Hypertension, Vol 23, 861-864, Copyright © 1994 by American Heart Association
KF Hilgers, W Fischli, R Veelken and JF Mann
Angiotensin I and II are generated by the vascular wall. Whether this
generation depends on renin or on other enzymes is debated. We tested the
hypothesis that remikiren, a highly specific inhibitor of human and guinea
pig renin, may inhibit the vascular renin-angiotensin system. Isolated
hindquarters from guinea pigs were perfused with an artificial medium, and
angiotensin I and II release was measured by high- performance liquid
chromatography and radioimmunoassay. Guinea pig hindquarters released
angiotensin I (23.8 +/- 5.6 fmol/30 min; n = 13) and angiotensin II (95.2
+/- 19 fmol/30 min; n = 13) spontaneously. Inhibition of the angiotensin
I-converting enzyme by captopril (10 nmol/mL) suppressed angiotensin II by
85% and increased angiotensin I by 352% (n = 5, P < .05). Infusion of
remikiren (1.6 nmol/mL) in addition to captopril decreased angiotensin I
release by 68% (P < .05 versus captopril alone, n = 5 each). We conclude
that renin generates angiotensin I in an isolated guinea pig resistance
vessel bed. Our study demonstrates that renin rather than nonrenin enzymes
is responsible for the major part of vascular angiotensin formation.
ARTICLES
Vascular renin in the guinea pig. Suppression by the renin inhibitor remikiren
Department of Medicine, University of Erlangen, Germany.
This article has been cited by other articles:
![]() |
D. N. Muller, K. F. Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann, and F. C. Luft Effects of Human Renin in the Vasculature of Rats Transgenic for Human Angiotensinogen Hypertension, August 1, 1995; 26(2): 272 - 278. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |